| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |